Pharmacy India
Pharmacy India is your ultimate destination for pharmacy exam preparation and career advancement. Discover top-notch study materials, daily quizzes, and expert courses for pharmacy exams like RRB Pharmacist, GPAT, and NIPER JEE, D.Pharma Exit Exam, etc.
Object – To prepare and dispense 20ml Aqueous Iodine Solution I.P. Reference – Gupta A.K., ‘Pharmaceutics-II Practical Notebook’, Published by CBS Publication, 2nd Edition, Page No. Requirements – Theory – Iodine is wider antiseptic agent which is effective against bacteria,…
Object – To prepare and dispense 20ml Piperazine citrate Elixir I.P. Reference – Mehta R. M., ‘Pharmaceutics-I’, Published by Vallabh Prakashan, 4th Edition 2007, Page No. 115. Requirements – Theory – Elixirs are hydroalcoholic liquids that are clear, sweetened, aromatic,…
Object – To prepare and dispense 50ml Simple Syrup I.P. Reference – Mehta R. M., ‘Pharmaceutics-I’, Published by Vallabh Prakashan, 4th Edition 2007, Page No. 113. Requirements – Theory – Syrups are concentrated solutions of sugar such as sucrose in…
Embarking on a career in pharmacy in Uttar Pradesh? Congratulations on taking the first step toward professional recognition! To ensure a seamless journey into the vibrant world of pharmaceuticals, understanding the process of obtaining new registration with the Uttar Pradesh Pharmacy Council is crucial.
A. Criteria of Minimum Qualification :-Candidate should Be :-1. D. Pharm (Diploma In Pharmacy)2. B. Pharm (Bachelor of Pharmacy)3. Pharm.D / Pharm.D (Post Baccalaureate)Above degree should be from the colleges having recognition from Pharmacy Council Of India. B. Training Certificate…
1. General Instructionsa. The applicant should be a Citizen of India and should have completed 18 years of age.b. Registerable Qualifications – D. Pharm, B. Pharm, Pharm D approved by Pharmacy Council of Indiac. Institution / College should have been…
M1 MedDRA Terminology M1: MedDRA- Medical Dictionary for Regulatory Activities M1: PtC WG MedDRA Points to Consider M2 Electronic Standards M2: EWG Electronic Standards for the Transfer of Regulatory Information M3 Nonclinical Safety Studies M3(R2): Guidance on Nonclinical Safety Studies…
E1: Clinical Safety for Drugs used in Long Term Treatment E1: The Extent Of Population Exposure To Assess Clinical Safety for Drugs intended for long term treatment of non-life threatening conditions. E2A-E2F: Pharmacovigilance E2A: Clinical Safety Data Management: Definitions and…
In order to identify potential dangers including carcinogenicity, genotoxicity, and reprotoxicity, ICH has created a thorough set of safety guidelines. A non-clinical testing approach for determining the QT interval prolongation liability—the leading factor in drug withdrawals in recent years—has made…
The performance of stability studies, establishing appropriate thresholds for impurity testing, and a more sensible approach to pharmaceutical quality based on Good Manufacturing Practice (GMP) risk assessment are all significant milestones in the harmonisation of the Quality domain. Q1A-Q1F: Stability…
This will close in 0 seconds
This will close in 0 seconds
